Optimization of Substituted 6-Salicyl-4-Anilinoquinazoline Derivatives as Dual EGFR/HER2 Tyrosine Kinase Inhibitors
2013 · PLoS ONE · 21 citations
https://doi.org/10.1371/journal.pone.0069427
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
117
Citations
6
h-index
5
i10-index
Jing‐Ran Li is an academic researcher from State Council of the People's Republic of China. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Cytokine Signaling Pathways and Interactions & Quinazolinone synthesis and applications. The author has an h-index of 6, co-authored 6 publications.
Click to start Chat